156 related articles for article (PubMed ID: 15241586)
1. Role of 5-lipoxygenase in the multiple organ failure induced by zymosan.
Cuzzocrea S; Rossi A; Serraino I; Di Paola R; Dugo L; Genovese T; Britti D; Sciarra G; De Sarro A; Caputi AP; Sautebin L
Intensive Care Med; 2004 Oct; 30(10):1935-43. PubMed ID: 15241586
[TBL] [Abstract][Full Text] [Related]
2. Role of interleukin-6 in a non-septic shock model induced by zymosan.
Cuzzocrea S; de Sarro G; Costantino G; Mazzon E; Laurà R; Ciriaco E; de Sarro A; Caputi AP
Eur Cytokine Netw; 1999 Jun; 10(2):191-203. PubMed ID: 10400825
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.
Cuzzocrea S; Mazzon E; Dugo L; Barbera A; Centorrino T; Ciccolo A; Fonti MT; Caputi AP
Shock; 2001 Jul; 16(1):51-8. PubMed ID: 11442316
[TBL] [Abstract][Full Text] [Related]
4. Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan.
Di Paola R; Esposito E; Mazzon E; Genovese T; Muià C; Crisafulli C; Malleo G; Sessa E; Meli R; Cuzzocrea S
Shock; 2006 Nov; 26(5):477-84. PubMed ID: 17047518
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat.
Cuzzocrea S; Costantino G; Mazzon E; Caputi AP
Crit Care Med; 1999 Aug; 27(8):1524-32. PubMed ID: 10470760
[TBL] [Abstract][Full Text] [Related]
6. Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide.
Cuzzocrea S; Zingarelli B; Sautebin L; Rizzo A; Crisafulli C; Campo GM; Costantino G; Calapai G; Nava F; Di Rosa M; Caputi AP
Shock; 1997 Oct; 8(4):268-75. PubMed ID: 9329128
[TBL] [Abstract][Full Text] [Related]
7. Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice.
Cuzzocrea S; Rossi A; Pisano B; Di Paola R; Genovese T; Patel NS; Cuzzocrea E; Ianaro A; Sautebin L; Fulia F; Chatterjee PK; Caputi AP; Thiemermann C
Intensive Care Med; 2003 Nov; 29(11):2016-25. PubMed ID: 12879239
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat.
Cuzzocrea S; Zingarelli B; Costantino G; Sottile A; Teti D; Caputi AP
Crit Care Med; 1999 Aug; 27(8):1517-23. PubMed ID: 10470759
[TBL] [Abstract][Full Text] [Related]
9. Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice.
Mondello S; Galuppo M; Mazzon E; Italiano D; Mondello P; Aloisi C; Cuzzocrea S
Eur J Pharmacol; 2011 May; 658(1):28-40. PubMed ID: 21349270
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Fulia F; Cuzzocrea E; Di Rosa M; Caputi AP; Thiemermann C
Crit Care Med; 2004 Feb; 32(2):457-66. PubMed ID: 14758164
[TBL] [Abstract][Full Text] [Related]
11. 5-Lipoxygenase knockout mice exhibit a resistance to pleurisy and lung injury caused by carrageenan.
Cuzzocrea S; Rossi A; Serraino I; Mazzon E; Di Paola R; Dugo L; Genovese T; Calabrò B; Caputi AP; Sautebin L
J Leukoc Biol; 2003 Jun; 73(6):739-46. PubMed ID: 12773506
[TBL] [Abstract][Full Text] [Related]
12. Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
Malleo G; Mazzon E; Genovese T; Di Paola R; Caminiti R; Esposito E; Bramanti P; Cuzzocrea S
Cytokine; 2008 Feb; 41(2):136-43. PubMed ID: 18160304
[TBL] [Abstract][Full Text] [Related]
13. Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat.
Cuzzocrea S; Imperatore F; Costantino G; Luongo C; Mazzon E; Scafuro MA; Mangoni G; Caputi AP; Rossi F; Filippelli A
Shock; 2000 Mar; 13(3):197-203. PubMed ID: 10718376
[TBL] [Abstract][Full Text] [Related]
14. 5-lipoxygenase knockout mice exhibit a resistance to splanchnic artery occlusion shock.
Cuzzocrea S; Rossi A; Serraino I; Di Paola R; Dugo L; Genovese T; Caputi AP; Sautebin L
Shock; 2003 Sep; 20(3):230-6. PubMed ID: 12923494
[TBL] [Abstract][Full Text] [Related]
15. The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat.
Dugo L; Chatterjee PK; Mazzon E; McDonald MC; Paola RD; Fulia F; Caputi AP; Thiemermann C; Cuzzocrea S
Intensive Care Med; 2002 Jun; 28(6):775-88. PubMed ID: 12107686
[TBL] [Abstract][Full Text] [Related]
16. PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice.
Di Paola R; Galuppo M; Mazzon E; Paterniti I; Bramanti P; Cuzzocrea S
Pharmacol Res; 2010 Feb; 61(2):175-87. PubMed ID: 19819333
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of M40401, a selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock.
Cuzzocrea S; Mazzon E; Di Paola R; Genovese T; Serraino I; Dugo L; Cuzzocrea E; Fulia F; Caputi AP; Salvemini D
Crit Care Med; 2004 Jan; 32(1):157-67. PubMed ID: 14707575
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of Hypericum perforatum in zymosan-induced multiple organ dysfunction syndrome: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity.
Di Paola R; Mazzon E; Muià C; Crisafulli C; Genovese T; Di Bella P; Esposito E; Menegazzi M; Meli R; Suzuki H; Cuzzocrea S
Nitric Oxide; 2007 Feb; 16(1):118-30. PubMed ID: 16889996
[TBL] [Abstract][Full Text] [Related]
19. Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice.
Genovese T; Di Paola R; Catalano P; Li JH; Xu W; Massuda E; Caputi AP; Zhang J; Cuzzocrea S
Crit Care Med; 2004 Jun; 32(6):1365-74. PubMed ID: 15187521
[TBL] [Abstract][Full Text] [Related]
20. GITR gene deletion and GITR-FC soluble protein administration inhibit multiple organ failure induced by zymosan.
Galuppo M; Nocentini G; Mazzon E; Ronchetti S; Esposito E; Riccardi L; Di Paola R; Bruscoli S; Riccardi C; Cuzzocrea S
Shock; 2011 Sep; 36(3):263-71. PubMed ID: 21654556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
